NEUTROLIS

neutrolis-logo

Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the immune system and play an important role in chronic and acute diseases. Although NETs represent one of the most important immunology discoveries in the past 20 years, there is no therapy on the market that effectively targets and removes NETs. Neutrolis was founded by two of the earliest and most cited leaders in the NETs field and s... upported by a seasoned biotech executive with a track record of successful M&A. The companyโ€™s pipeline includes NTR-441 and NTR-10, that effectively removes NETs and halt their pathologic effects on end-organs. Neutrolis has a strong patent portfolio for new molecular entity and method of use. The lead molecule, NTR-441, is slated to enter clinical trials in 2021.

#SimilarOrganizations #People #Financial #Website #More

NEUTROLIS

Social Links:

Industry:
Biotechnology Life Science Medical

Founded:
2017-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.neutrolis.com

Total Employee:
1+

Status:
Active

Total Funding:
23.14 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box Organization Schema


Similar Organizations

aulos-bioscience-logo

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

imago-biosciences-logo

Imago BioSciences

Imago is a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs).

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

third-harmonic-bio-logo

Third Harmonic Bio

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.

Current Employees Featured

john-sundy_image

John Sundy
John Sundy Board Of Directors @ Neutrolis
Board Of Directors
2022-01-01

abdul-hakkim_image

Abdul Hakkim
Abdul Hakkim Co-Founder, Co-President, and COO @ Neutrolis
Co-Founder, Co-President, and COO
2021-10-01

toby-fox_image

Toby Fox
Toby Fox Co-founder & CEO @ Neutrolis
Co-founder & CEO
2020-06-01

Founder


abdul-hakkim_image

Abdul Hakkim

toby-fox_image

Toby Fox

Investors List

prefix-capital_image

Prefix Capital

Prefix Capital investment in Venture Round - Neutrolis

Official Site Inspections

http://www.neutrolis.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Neutrolis" on Search Engine